US 7033582
Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
expired A61KA61K31/785A61K38/02
Quick answer
US patent 7033582 (Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Apr 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/785, A61K38/02